(Q35808002)

10 August 2017

Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis (English)

1 reference

10 August 2017

0 references

5

Lazaros I Sakkas

1 reference

10 August 2017

Ioannis Alexiou

1

1 reference

10 August 2017

Anastasios Germenis

series ordinal

2

1 reference

10 August 2017

Athanasios Ziogas

series ordinal

3

1 reference

10 August 2017

Katerina Theodoridou

series ordinal

4

1 reference

10 August 2017

20 April 2007

1 reference

BMC Musculoskeletal Disorders

10 August 2017

1 reference

10 August 2017

8

1 reference

10 August 2017

37

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2474-8-37

10 August 2017

0 references

cites work

Use and significance of anti-CCP autoantibodies in rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1876231

Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1876231

Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1876231

Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP).

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1876231

Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project).

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1876231

Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1876231

The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1876231

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1876231

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1876231

HLA class II sequence polymorphisms and susceptibility to rheumatoid arthritis in Greeks. The HLA-DR beta shared-epitope hypothesis accounts for the disease in only a minority of Greek patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1876231

Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1876231

Guidelines for the management of rheumatoid arthritis: 2002 Update

27 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-8-37

Autoantibodies in rheumatoid arthritis and their clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-8-37

Modifications of arginines and their role in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-8-37

The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-8-37

Clinical utility of the anti-CCP assay in patients with rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-8-37

High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-8-37

Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-8-37

Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-8-37

Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-8-37

Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-8-37

A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-8-37

Autoantibodies recognizing citrullinated rat filaggrin in an ELISA using citrullinated and non-citrullinated recombinant proteins as antigens are highly diagnostic for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-8-37

Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1876231

How to apply Larsen score in evaluating radiographs of rheumatoid arthritis in long-term studies.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1876231

How to diagnose rheumatoid arthritis early: A prediction model for persistent (erosive) arthritis

25 September 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-8-37

Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-8-37

21 January 2018

Identifiers

DOI

10.1186/1471-2474-8-37

1 reference

Dimensions Publication ID

10 August 2017

0 references

1 reference

10 August 2017

1 reference